Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 84.70
-0.70 (-0.82%)
Apr 17, 2026, 1:58 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5.69 billion as of April 17, 2026. Its market cap has increased by 297.40% in one year.
Market Cap
5.69B
Enterprise Value
5.26B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
84.70
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.69B, an increase of 154.02%. That is a compound annual growth rate of 55.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 5.69B | 42.10% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acepodia | 7.25B |
| Savior Lifetec | 6.18B |
| Mycenax Biotech | 6.18B |
| Sinphar Pharmaceutical | 6.11B |
| AnnJi Pharmaceutical | 5.75B |
| Panion & Bf Biotech | 5.53B |
| UnicoCell Biomed | 5.17B |
| OBI Pharma | 4.99B |